menu
    • menu

    Find Axitinib manufacturers, exporters & distributors on PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    25

    API Suppliers

    API Suppliers

    6

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    5

    EU WC

    EU WC

    0

    KDMF

    KDMF

    4

    NDC API

    NDC API

    0

    VMF

    NDC API

    19

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 453,498

    MARKET PLACE

    6

    API

    0

    FDF

    19INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    40

    FDF Dossiers

    FDF Dossiers

    6

    FDA Orange Book

    FDA (Orange Book)

    22

    Europe

    Europe

    2

    Canada

    Canada

    4

    Australia

    Australia

    2

    South Africa

    South Africa

    4

    Listed Dossiers

    Listed Dossiers

    39DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    16

    US Patents

    0

    US Exclusivities

    8

    Health Canada Patents

    DIGITAL CONTENT

    2

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    75

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    417,577,746

    Annual Reports

    5,781

    Finished Drug Prices

    Listed Dossiers

    91 RELATED EXCIPIENT COMPANIES

    140EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 319460-85-0, Ag-013736, Inlyta, Ag 013736, (e)-n-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1h-indazol-6-yl)thio)benzamide, Ag-13736
    Molecular Formula
    C22H18N4OS
    Molecular Weight
    386.5  g/mol
    InChI Key
    RITAVMQDGBJQJZ-FMIVXFBMSA-N
    FDA UNII
    C9LVQ0YUXG
    Axitinib
    A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
    Axitinib is a Kinase Inhibitor. The mechanism of action of axitinib is as a Receptor Tyrosine Kinase Inhibitor.
    1 2D Structure

    Axitinib

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
    2.1.2 InChI
    InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+
    2.1.3 InChI Key
    RITAVMQDGBJQJZ-FMIVXFBMSA-N
    2.1.4 Canonical SMILES
    CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4
    2.1.5 Isomeric SMILES
    CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4
    2.2 Other Identifiers
    2.2.1 UNII
    C9LVQ0YUXG
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Ag 013736

    2. Ag-013736

    3. Ag013736

    4. Inlyta

    2.3.2 Depositor-Supplied Synonyms

    1. 319460-85-0

    2. Ag-013736

    3. Inlyta

    4. Ag 013736

    5. (e)-n-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1h-indazol-6-yl)thio)benzamide

    6. Ag-13736

    7. Ag013736

    8. C9lvq0yuxg

    9. N-methyl-2-((3-((1e)-2-(pyridin-2-yl)ethenyl)-1h-indazol-6-yl)sulfanyl)benzamide

    10. Nsc-757441

    11. Chebi:66910

    12. (e)-n-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1h-indazol-6-ylthio)benzamide

    13. N-methyl-2-[[3-[(e)-2-pyridin-2-ylethenyl]-1h-indazol-6-yl]sulfanyl]benzamide

    14. Nsc757441

    15. N-methyl-2-({3-[(e)-2-(pyridin-2-yl)ethenyl]-1h-indazol-6-yl}sulfanyl)benzamide

    16. Ncgc00241108-01

    17. S1005

    18. Dsstox_cid_28975

    19. Dsstox_rid_83240

    20. Dsstox_gsid_49049

    21. Axitinib (ag 013736)

    22. N-methyl-2-({3-[(e)-2-(pyridin-2-yl)vinyl]-1h-indazol-6-yl}sulfanyl)benzamide

    23. N-methyl-2-(3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl)-benzamide

    24. Axitinib [usan]

    25. Cas-319460-85-0

    26. Unii-c9lvq0yuxg

    27. Axitinibum

    28. Axitinib [usan:inn:jan]

    29. 4agc

    30. Benzamide, N-methyl-2-((3-((1e)-2-(2-pyridinyl)ethenyl)-1h-indazol-6-yl)thio)-

    31. Benzamide, N-methyl-2-[[3-[(1e)-2-(2-pyridinyl)ethenyl]-1h-indazol-6-yl]thio]-

    32. Inlyta (tn)

    33. Mfcd09837898

    34. Ag13736

    35. 4ag8

    36. Axitinib (jan/usan)

    37. Axitinib [inn]

    38. Axitinib [jan]

    39. Axitinib [mi]

    40. Axitinib [vandf]

    41. Axitinib [mart.]

    42. Ag-013736;axitinib

    43. Axitinib [who-dd]

    44. Axitinib,ag-013736

    45. Mls006010164

    46. Schembl172918

    47. Axitinib [orange Book]

    48. Gtpl5659

    49. Axitinib, >=98% (hplc)

    50. Chembl1289926

    51. Dtxsid3049049

    52. N-methyl-2-[[3-[2-(2-pyridinyl)ethenyl]-1h-indazol-6-yl]thio]benzamide

    53. Schembl22930506

    54. Bdbm25117

    55. Chebi:94568

    56. Ex-a337

    57. Bcpp000372

    58. Bcp01371

    59. Zinc3816287

    60. Tox21_113597

    61. Nsc799341

    62. Akos015902898

    63. Tox21_113597_1

    64. Ac-1539

    65. Bcp9000345

    66. Ccg-264772

    67. Cs-0116

    68. Db06626

    69. Ks-1448

    70. Nsc 757441

    71. Nsc-799341

    72. Benzamide, N-methyl-2-((3-((e)-2-(2-pyridinyl)ethenyl)-1h-indazol-6-yl)thio)-

    73. Ncgc00241108-04

    74. Ncgc00241108-06

    75. Hy-10065

    76. Smr002530046

    77. Am20090673

    78. Sw219464-1

    79. D03218

    80. Ab01274739-01

    81. Ab01274739_02

    82. 460a850

    83. Sr-01000941566

    84. J-502064

    85. Q-200662

    86. Q4830631

    87. Sr-01000941566-1

    88. Brd-k29905972-001-01-4

    89. Brd-k29905972-001-02-2

    90. Benzamide, N-methyl-2-((3-((1e)-2-(2-pyridinyl)ethenyl)-1h-indazo)-6-yl)thio)-

    91. N-methyl-[[3[(1e)-2-(2-pyridinyl)ethenyl]-1h-indazol-6-yl]thio]-benzamide

    92. N-methyl-2((3-((1e0-2-(pyridin-2-yl)ethenyl)-1h-inazol-6-ylsufanyl)benzamide

    93. N-methyl-2-({3-[(e)-2-pyridin-2-ylethenyl]-2h-indazol-6-yl}sulfanyl)benzamide

    2.4 Create Date
    2006-04-29
    3 Chemical and Physical Properties
    Molecular Weight 386.5 g/mol
    Molecular Formula C22H18N4OS
    XLogP34.2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count5
    Exact Mass386.12013238 g/mol
    Monoisotopic Mass386.12013238 g/mol
    Topological Polar Surface Area96 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity557
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameInlyta
    PubMed HealthAxitinib (By mouth)
    Drug ClassesAntineoplastic Agent
    Drug LabelINLYTA (axitinib) is a kinase inhibitor. Axitinib has the chemical name N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide. The molecular formula is C22H18N4OS and the molecular weight is 386.47 Daltons. The chemical structur...
    Active IngredientAxitinib
    Dosage FormTablet
    RouteOral
    Strength1mg; 5mg
    Market StatusPrescription
    CompanyPfizer

    2 of 2  
    Drug NameInlyta
    PubMed HealthAxitinib (By mouth)
    Drug ClassesAntineoplastic Agent
    Drug LabelINLYTA (axitinib) is a kinase inhibitor. Axitinib has the chemical name N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide. The molecular formula is C22H18N4OS and the molecular weight is 386.47 Daltons. The chemical structur...
    Active IngredientAxitinib
    Dosage FormTablet
    RouteOral
    Strength1mg; 5mg
    Market StatusPrescription
    CompanyPfizer

    4.2 Drug Indication

    Used in kidney cell cancer and investigated for use/treatment in pancreatic and thyroid cancer.

    FDA Label

    Inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of prior treatment with sunitinib or a cytokine.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Axitinib prevents the progression of cancer by inhibiting angiogenesis and blocking tumor growth.

    5.2 MeSH Pharmacological Classification

    Antineoplastic Agents

    Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

    Protein Kinase Inhibitors

    Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    AXITINIB
    5.3.2 FDA UNII
    C9LVQ0YUXG
    5.3.3 Pharmacological Classes
    Receptor Tyrosine Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]
    5.4 ATC Code

    L01EK01

    L01XE17

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    L - Antineoplastic and immunomodulating agents

    L01 - Antineoplastic agents

    L01E - Protein kinase inhibitors

    L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors

    L01EK01 - Axitinib

    5.5 Absorption, Distribution and Excretion

    Absorption

    After one 5 mg dose of axitinib, it takes about 2.5 to 4.1 hours to reach maximum plasma concentration.

    Route of Elimination

    Axitinib is mainly eliminated unchanged in the feces (41%) with 12% of the original dose as unchanged axitinib. There is also 23% eliminated in the urine, most of which are metabolites.

    Volume of Distribution

    The volume of distribution is 160 L.

    Clearance

    The average clearance of axitinib is 38 L/h.

    5.6 Metabolism/Metabolites

    Axitinib undergoes mainly hepatic metabolism. CYP3A4 and CYP3A5 are the main hepatic enzymes while CYP1A2, CYP2C19, and UGT1A1 enzymes are secondary.

    5.7 Biological Half-Life

    Axitinib has a half life of 2.5 to 6.1 hours.

    5.8 Mechanism of Action

    Axitinib selectively blocks the tyrosine kinase receptors VEGFR-1 (vascular endothelial growth factor receptor), VEGFR-2, and VEGFR-3.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"AXITINIB","year":"2021","qtr":"Q1","strtotime":1614277800,"product":"AXITINIB","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"TECOLAND CORPORATION","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.005","unit":"KGS","unitRateFc":"548730.1","totalValueFC":"2715.1","currency":"USD","unitRateINR":39536000,"date":"26-Feb-2021","totalValueINR":"197680","totalValueInUsd":"2715.1","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"8942093","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AXITINIB","year":"2021","qtr":"Q1","strtotime":1615919400,"product":"AXITINIB(NON-MINCRONIZED MATERIAL IN ALI QUOT)","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"CHICAGO IL","customer":"ALCON INC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.002","unit":"KGS","unitRateFc":"551145.1","totalValueFC":"1090.9","currency":"USD","unitRateINR":39710005,"date":"17-Mar-2021","totalValueINR":"79420.01","totalValueInUsd":"1090.9","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"9432534","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AXITINIB","year":"2021","qtr":"Q1","strtotime":1617042600,"product":"AXITINIB","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"TECOLAND CORPORATION","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"538290.1","totalValueFC":"5327.3","currency":"USD","unitRateINR":38783800,"date":"30-Mar-2021","totalValueINR":"387838","totalValueInUsd":"5327.3","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"9751942","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AXITINIB","year":"2021","qtr":"Q2","strtotime":1619461800,"product":"AXITINIB","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"TECOLAND CORPORATION","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"560757.8","totalValueFC":"5426.9","currency":"USD","unitRateINR":40402600,"date":"27-Apr-2021","totalValueINR":"404026","totalValueInUsd":"5426.9","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"1395748","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634754600,"product":"AXITINIB","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"TIANJIN","customer":"BENOVA (TIANJIN)PHARMA CO.,LTD","customerCountry":"CHINA","quantity":"0.59","actualQuantity":"0.594","unit":"KGS","unitRateFc":"220000","totalValueFC":"128430.7","currency":"USD","unitRateINR":16196969.696969697,"date":"21-Oct-2021","totalValueINR":"9621000","totalValueInUsd":"128430.7","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"5457150","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635791400,"product":"AXITINIB","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"ALCAMI","customerCountry":"UNITED STATES","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"621000","totalValueFC":"18248.7","currency":"USD","unitRateINR":45300000,"date":"02-Nov-2021","totalValueINR":"1359000","totalValueInUsd":"18248.7","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"5764004","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640716200,"product":"AXITINIB","address":"12 6 214 A1, YERMARUS CAMP CROSS,H YDERABAD ROAD","city":"RAICHUR,KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"CHICAGO, IL","customer":"ALCON INC","customerCountry":"UNITED STATES","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"600000","totalValueFC":"60019","currency":"USD","unitRateINR":45270000,"date":"29-Dec-2021","totalValueINR":"4527000","totalValueInUsd":"60019","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"7095401","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"12 6 214 A1, YERMARUS CAMP CROSS,H YDERABAD ROAD, RAICHUR,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648405800,"product":"AXITINIB","address":"12 6 214 A1, YERMARUS CAMP CROSS,H YDERABAD ROAD","city":"RAICHUR,KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"TECOLAND CORPORATION","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"568000","totalValueFC":"5353","currency":"USD","unitRateINR":40800000,"date":"28-Mar-2022","totalValueINR":"408000","totalValueInUsd":"5353","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"9264498","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"12 6 214 A1, YERMARUS CAMP CROSS,H YDERABAD ROAD, RAICHUR,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672338600,"product":"AXITINIB WS","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR CONTA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER OF","customerCountry":"BRAZIL","quantity":"0.00","actualQuantity":"0.5","unit":"GMS","unitRateFc":"3000","totalValueFC":"1225.6","currency":"USD","unitRateINR":202000,"date":"30-Dec-2022","totalValueINR":"101000","totalValueInUsd":"1225.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6583422","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR CONTA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674239400,"product":"AXITINIB 6-IODOINDAZOLE","address":"GREEN ACRES PH-III, B-1-502, WAGHBILL ROAD, THANE","city":"Thane","supplier":"OMA ANALYTICAL SERVICES","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"M\/S. VEEPRHO RESEARCH INC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.09","unit":"GMS","unitRateFc":"177.8","totalValueFC":"12.2","currency":"USD","unitRateINR":11111.111111111111,"date":"21-Jan-2023","totalValueINR":"1000","totalValueInUsd":"12.2","indian_port":"BOMBAY AIR","hs_no":"29221990","bill_no":"7158894","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"GREEN ACRES PH-III, B-1-502, WAGHBILL ROAD, THANE, Thane","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"BULK DRUG ( AXITINIB STANDARDS )","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"ALCAMI","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"120000","totalValueFC":"5920.8","currency":"USD","unitRateINR":9780000,"date":"28-Feb-2023","totalValueINR":"489000","totalValueInUsd":"5920.8","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"8143752","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"BULK DRUG ( AXITINIB STANDARDS )","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"ALCAMI","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.3","unit":"GMS","unitRateFc":"225000","totalValueFC":"66678.8","currency":"USD","unitRateINR":18356666.666666668,"date":"28-Feb-2023","totalValueINR":"5507000","totalValueInUsd":"66678.8","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"8143752","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697135400,"product":"AXITINIB","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"PHILADELPHIA METROP","customer":"TO THE ORDER OF","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"555","totalValueFC":"2511.1","currency":"USD","unitRateINR":41800,"date":"13-Oct-2023","totalValueINR":"209000","totalValueInUsd":"2511.1","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"4620392","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701109800,"product":"BULK DRUG( AXITINIB )","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"CLOUDBREAK PHARMA SUZHOU,","customerCountry":"CHINA","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"600","totalValueFC":"5920.4","currency":"USD","unitRateINR":49300,"date":"28-Nov-2023","totalValueINR":"493000","totalValueInUsd":"5920.4","indian_port":"Madras Air","hs_no":"29420090","bill_no":"5647520","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Madras Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713465000,"product":"AXITINIB","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"LYOTROPIC DELIVERI SYSTEM(LDS) LTD","customerCountry":"ISRAEL","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"220","totalValueFC":"1951.9","currency":"USD","unitRateINR":16300,"date":"19-Apr-2024","totalValueINR":"163000","totalValueInUsd":"1951.9","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"9241513","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730140200,"product":"AXITINIB","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"TECOLAND CORPORATION","customerCountry":"UNITED STATES","quantity":"0.02","actualQuantity":"20","unit":"GMS","unitRateFc":"559","totalValueFC":"10869.2","currency":"USD","unitRateINR":45665.050000000003,"date":"29-Oct-2024","totalValueINR":"913301","totalValueInUsd":"10869.2","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5255882","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647369000,"product":"RE-IMPORTS- AXITINIB IMPURITY 29 (AXITINIB IMPURITY A) (N.C.V )","address":"Z-A-1 BLOCK PART OF,APM-II,,PHASE- II, SEC-19B VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SC \\\"VEROPHARM\\\"","supplierCountry":"INDIA","foreign_port":"NA","customer":"THETABETA ANALGORITHMS PRIVATE ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.3","unit":"GMS","unitRateFc":"16.7","totalValueFC":"5.1","currency":"USD","unitRateINR":"1291.8","date":"16-Mar-2022","totalValueINR":"387.55","totalValueInUsd":"5.1","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"7888041","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Z-A-1 BLOCK PART OF,APM-II,,PHASE- II, SEC-19B VASHI"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647369000,"product":"RE-IMPORTS- AXITINIB IMPURITY D (N.C.V )","address":"Z-A-1 BLOCK PART OF,APM-II,,PHASE- II, SEC-19B VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SC \\\"VEROPHARM\\\"","supplierCountry":"INDIA","foreign_port":"NA","customer":"THETABETA ANALGORITHMS PRIVATE ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.3","unit":"GMS","unitRateFc":"33.3","totalValueFC":"10.2","currency":"USD","unitRateINR":"2583.7","date":"16-Mar-2022","totalValueINR":"775.12","totalValueInUsd":"10.2","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"7888041","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Z-A-1 BLOCK PART OF,APM-II,,PHASE- II, SEC-19B VASHI"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659983400,"product":"AXITINIB MICRONIZED API ANHYDROUS SAB-1 PACKED IN 1G ALIQUOTS","address":"NO.49, F1 F2 CANARA BANK ROAD BOMMASANDRA INDL AREA PHASE I","city":"BENGALURU","supplier":"OCULAR THERAPEUTIX","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ANTHEM BIOSCIENCES","customerCountry":"INDIA","quantity":"0.04","actualQuantity":"40","unit":"GMS","unitRateFc":"525","totalValueFC":"21180.2","currency":"USD","unitRateINR":"42131.3","date":"09-Aug-2022","totalValueINR":"1685250","totalValueInUsd":"21180.2","indian_port":"BANGALORE AIR","hs_no":"29334900","bill_no":"9931954","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Micronized","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.49, F1 F2 CANARA BANK ROAD BOMMASANDRA INDL AREA PHASE I"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1680287400,"product":"AXITINIB 20G (RE-IMPORT OF REJECTED GOODS) [EXPORT SB NO.6249320 DT.19\/12\/2022]","address":"","city":"","supplier":"TECOLAND CORPORATION","supplierCountry":"INDIA","foreign_port":"NA","customer":"SHILPA PHARMA LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"20","unit":"GMS","unitRateFc":"559","totalValueFC":"11418.2","currency":"USD","unitRateINR":"46788.3","date":"01-Apr-2023","totalValueINR":"935766","totalValueInUsd":"11418.2","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"5332944","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":""}]
    26-Feb-2021
    29-Oct-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Granulation

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Axitinib Manufacturers

    A Axitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Axitinib, including repackagers and relabelers. The FDA regulates Axitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Axitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Axitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Axitinib Suppliers

    A Axitinib supplier is an individual or a company that provides Axitinib active pharmaceutical ingredient (API) or Axitinib finished formulations upon request. The Axitinib suppliers may include Axitinib API manufacturers, exporters, distributors and traders.

    click here to find a list of Axitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Axitinib USDMF

    A Axitinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Axitinib active pharmaceutical ingredient (API) in detail. Different forms of Axitinib DMFs exist exist since differing nations have different regulations, such as Axitinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Axitinib DMF submitted to regulatory agencies in the US is known as a USDMF. Axitinib USDMF includes data on Axitinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Axitinib USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Axitinib suppliers with USDMF on PharmaCompass.

    Axitinib WC

    A Axitinib written confirmation (Axitinib WC) is an official document issued by a regulatory agency to a Axitinib manufacturer, verifying that the manufacturing facility of a Axitinib active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Axitinib APIs or Axitinib finished pharmaceutical products to another nation, regulatory agencies frequently require a Axitinib WC (written confirmation) as part of the regulatory process.

    click here to find a list of Axitinib suppliers with Written Confirmation (WC) on PharmaCompass.

    Axitinib NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Axitinib as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Axitinib API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Axitinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Axitinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Axitinib NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Axitinib suppliers with NDC on PharmaCompass.

    Axitinib GMP

    Axitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Axitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Axitinib GMP manufacturer or Axitinib GMP API supplier for your needs.

    Axitinib CoA

    A Axitinib CoA (Certificate of Analysis) is a formal document that attests to Axitinib's compliance with Axitinib specifications and serves as a tool for batch-level quality control.

    Axitinib CoA mostly includes findings from lab analyses of a specific batch. For each Axitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Axitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Axitinib EP), Axitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Axitinib USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search